CARE Ratings Limited Reports Strong Q3 FY26 Results with 15% Revenue Growth

2 min read     Updated on 11 Feb 2026, 07:04 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

CARE Ratings Limited reported strong Q3 FY26 results with standalone revenue growing 15% YoY to Rs. 90.24 crores and consolidated revenue up 16% to Rs. 112.12 crores. For 9M FY26, standalone revenue reached Rs. 280.15 crores (14% growth) while consolidated revenue stood at Rs. 342.40 crores (17% growth). The ratings segment contributed 89% of revenue with Rs. 305.69 crores, growing 17% YoY, while maintaining healthy EBITDA margins of 46% for standalone operations.

32362452

*this image is generated using AI for illustrative purposes only.

CARE Ratings Limited has announced its unaudited financial results for the quarter and nine months ended December 31, 2025, demonstrating strong operational performance across both standalone and consolidated metrics. The company's results reflect sustained growth momentum despite mixed conditions in the domestic debt market.

Financial Performance Overview

The company delivered impressive growth across key financial metrics for Q3 FY26:

Metric Standalone Q3 FY26 YoY Growth Consolidated Q3 FY26 YoY Growth
Revenue from Operations Rs. 90.24 Crs 15% Rs. 112.12 Crs 16%
EBITDA Rs. 37.23 Crs 23% Rs. 40.34 Crs 33%
EBITDA Margin 41% - 36% -
PAT Rs. 36.06 Crs 22% Rs. 36.54 Crs 29%
PAT Margin 35% - 29% -
EPS Rs. 12.01 - Rs. 11.96 -

For the nine months ended December 31, 2025, the performance metrics showed consistent growth:

Metric Standalone 9M FY26 YoY Growth Consolidated 9M FY26 YoY Growth
Revenue from Operations Rs. 280.15 Crs 14% Rs. 342.40 Crs 17%
EBITDA Rs. 129.50 Crs 18% Rs. 136.64 Crs 27%
EBITDA Margin 46% - 40% -
PAT Rs. 121.01 Crs 17% Rs. 120.25 Crs 24%
PAT Margin 38% - 32% -
EPS Rs. 40.35 - Rs. 39.46 -

Segment-wise Revenue Analysis

The company's revenue composition for 9M FY26 demonstrates the dominance of its core ratings business while showing growth across segments:

Segment Revenue (Rs. Crores) YoY Growth Contribution
Ratings Segment 305.69 17% 89%
Non-Ratings Segment 36.71 21% 11%

The ratings segment continues to be the primary revenue driver, contributing 89% of total consolidated revenue with strong 17% year-on-year growth. The non-ratings segment, while smaller in absolute terms, showed robust 21% growth, indicating successful diversification efforts.

Management Commentary

Mehul Pandya, Managing Director & Group CEO of CareEdge, highlighted the company's performance despite mixed market conditions. He emphasized that standalone revenue from operations grew by 15% year-on-year in Q3 FY26, driven by stable rating volumes and broad-based growth across segments. The management noted that consolidated revenue growth of 16% in Q3 FY26 and 17% in 9M FY26 was supported by continued contribution from non-ratings businesses.

The company reported a robust standalone EBITDA margin of 46% for 9M FY26, reflecting disciplined cost management and operational efficiencies. Management expressed cautious optimism about the outlook, supported by improving credit demand, healthy capital market activity, and continued focus on governance and analytical rigor.

Market Context

The results come against a backdrop of mixed debt market conditions. Corporate bond issuances were lower by 11% year-on-year in Q3 FY26, while commercial paper issuances moderated by 6% during the quarter. However, cumulative commercial paper issuances for 9M FY26 remained healthy with 10.3% year-on-year growth. Bank credit offtake accelerated to 14.5% as of December 2025, up from 11.2% growth in the corresponding period of the previous year, indicating improving credit demand in the economy.

Historical Stock Returns for CARE Ratings

1 Day5 Days1 Month6 Months1 Year5 Years
-1.30%-1.06%-1.39%-4.28%+27.86%+236.73%

CARE Ratings Limited Announces Changes in Board Committee Composition

1 min read     Updated on 20 Jan 2026, 04:47 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

CARE Ratings Limited announced changes in Board Committee composition effective immediately following a January 20, 2026 Board meeting. The restructuring affects three key committees with new leadership appointments: Mr. Manoj Chugh leads the Nomination and Remuneration Committee, Ms. Indrani Banerjee chairs the Stakeholders Relationship Committee, and Mr. Rajiv Bansal heads the Strategy and Investment Committee. The changes demonstrate the company's commitment to enhanced governance effectiveness and regulatory compliance.

30453431

*this image is generated using AI for illustrative purposes only.

CARE Ratings Limited has announced significant changes in the composition of its Board Committees, effective immediately following a Board of Directors meeting held on January 20, 2026. The company informed stock exchanges about these organizational restructuring decisions in compliance with SEBI regulations.

The Board meeting, which commenced at 2:30 p.m. and concluded at 4:15 p.m., focused on approving changes in the composition of various Board Committees. The company has communicated these changes to both BSE Limited and The National Stock Exchange of India Ltd., ensuring full regulatory compliance under Regulation 30 and Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Revised Committee Structure

The restructuring affects three major Board Committees, with new leadership appointments and member reallocations designed to enhance governance effectiveness.

Nomination and Remuneration Committee

The Nomination and Remuneration Committee has been reconstituted with the following composition:

Position: Member Name
Chairperson: Mr. Manoj Chugh
Member: Mr. G. Mahalingam
Member: Mr. V. Chandrasekaran
Member: Dr. Bimal Patel

Stakeholders Relationship Committee

The Stakeholders Relationship Committee features new leadership and member structure:

Position: Member Name
Chairperson: Ms. Indrani Banerjee
Member: Mr. Sobhag Mal Jain
Member: Dr. Bimal Patel
Member: Mr. Mehul Pandya

Strategy and Investment Committee

The Strategy and Investment Committee has been expanded with five members under new leadership:

Position: Member Name
Chairperson: Mr. Rajiv Bansal
Member: Mr. V. Chandrasekaran
Member: Mr. G. Mahalingam
Member: Mr. Manoj Chugh
Member: Dr. Bimal Patel

Regulatory Compliance and Communication

The company has ensured full transparency by making this information available on its official website at www.careedge.in , in addition to formal notifications to stock exchanges. The announcement was signed by Manoj Kumar CV, Company Secretary & Compliance Officer, demonstrating the company's commitment to proper governance protocols and regulatory adherence.

These committee restructuring changes reflect CARE Ratings Limited's ongoing efforts to optimize its governance framework and ensure effective oversight across key operational areas including nomination processes, stakeholder relations, and strategic investment decisions.

Historical Stock Returns for CARE Ratings

1 Day5 Days1 Month6 Months1 Year5 Years
-1.30%-1.06%-1.39%-4.28%+27.86%+236.73%

More News on CARE Ratings

1 Year Returns:+27.86%